OCM
PFE icon

Oakwood Capital Management’s Pfizer PFE Stock Holding History

Oakwood Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-133,279
Closed -$4.13M – 56
2020
Q1 		$4.13M Buy
133,279
+917
+0.7% +$31.2K 2.18% 22
2019
Q4 		$4.92M Sell
132,362
-4,702
-3% -$167K 2.05% 26
2019
Q3 		$4.67M Sell
137,064
-4,079
-3% -$148K 2.07% 24
2019
Q2 		$5.8M Buy
141,143
+7,114
+5% +$282K 2.49% 17
2019
Q1 		$5.4M Sell
134,029
-5,539
-4% -$222K 2.27% 24
2018
Q4 		$5.78M Sell
139,568
-5,275
-4% -$219K 2.71% 16
2018
Q3 		$6.06M Sell
144,843
-2,250
-2% -$86.6K 2.45% 20
2018
Q2 		$5.06M Sell
147,093
-4,791
-3% -$164K 2.13% 25
2018
Q1 		$5.11M Sell
151,884
-250
-0.2% -$8.6K 2.18% 25
2017
Q4 		$5.23M Sell
152,134
-3,400
-2% -$116K 1.16% 39
2017
Q3 		$5.27M Sell
155,534
-1,733
-1% -$55.7K 1.23% 33
2017
Q2 		$5.01M Sell
157,267
-5,623
-3% -$177K 1.24% 30
2017
Q1 		$5.29M Buy
162,890
+24,118
+17% +$760K 1.32% 30
2016
Q4 		$4.28M Sell
138,772
-29,143
-17% -$890K 1.09% 41
2016
Q3 		$5.4M Buy
167,915
+1,268
+0.8% +$42.4K 1.39% 33
2016
Q2 		$5.57M Sell
166,647
-3,241
-2% -$103K 1.45% 31
2016
Q1 		$4.78M Buy
169,888
+22,164
+15% +$633K 1.26% 37
2015
Q4 		$4.52M Sell
147,724
-13,407
-8% -$422K 1.22% 39
2015
Q3 		$4.8M Buy
+161,131
New +$5.17M 1.34% 34
2014
Q4 		– Sell
-7,836
Closed -$220K – 99
2014
Q3 		$220K Buy
+7,836
New +$220K 0.06% 80
2013
Q4 		– Sell
-7,383
Closed -$201K – 77
2013
Q3 		$201K Sell
7,383
-1,118
-13% -$30.4K 0.07% 67
2013
Q2 		$226K Buy
+8,501
New +$235K 0.09% 64

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Oakwood Capital Management's PFE Position: Q2 2020 in Review

Oakwood Capital Management sold out of Pfizer (PFE) in Q2 2020, closing a stake of 133,279 shares — an estimated $4.13M sold.

Oakwood Capital Management first reported a position in PFE in Q2 2013 and held it in 22 quarters. The position peaked at $6.06M in Q3 2018. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Oakwood Capital Management reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
  • Oakwood Capital Management sold 133,279 Pfizer shares in Q2 2020, an estimated $4.13M.
  • Oakwood Capital Management first reported a position in Pfizer in Q2 2013 and held it in 22 quarters.
  • Oakwood Capital Management's Pfizer position peaked at $6.06M in Q3 2018.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Oakwood Capital Management's 13F filing for Q2 2020, filed 23 Jul 2020.